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Abstract 
A glass of the composition 57%SiO2, 3%Al2O3, 34%CaO and 6%Na2O has been produced as a 
powder and deposited by plasma spray on titanium alloy and stainless steel substrates. The obtained 
coated samples have been subjected to a patented ion-exchange treatment to introduce ionic silver 
on material surfaces and so induce antibacterial activity. Silver surface-enriched samples have been 
characterized by means of X-ray diffraction, SEM observation, EDS analysis, in vitro bioactivity 
test, leaching test by GFAAS (graphite furnace atomic adsorption spectroscopy) analyses, cells 
adhesion and proliferation, and antibacterial tests using Staphylococcus Aureus strain. In vitro tests 
results demonstrate that the modified samples acquire an antimicrobial action against tested 
bacteria, without affecting the biocompatibility of the glass.  
The ion-exchange treatment can be successfully applied to glass-coated samples without affecting 
the properties of the coatings. Finally, this method could be also proposed for other glass or glass-
ceramic coatings, of proper composition, to produce coated devices for bone healing and/or 
prostheses, able to reduce bacterial colonization and reducing the infections risks. 
 
 
1. Introduction 
Medical devices for implants and prostheses are commonly realized with metallic materials, such as 
steel or titanium alloys, as they provide satisfactory results as regards mechanical and biological 
behaviour. Metals can be considered as inert materials as they do not have any interaction with bone 
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tissue cells, being the adhesion between the device and the host tissue based only on the mechanical 
bonding of surfaces. Moreover, metals do not provide any protection against bacteria adhesion, 
representing a good environment for the colonization of the material surfaces, especially when they 
are subjected to enroughness treatments (such as sand blasting, acid etching…) [1,2].  
Despite the use of hygienic protocols and preventive antibiotic prophylaxes, the infections 
development remains one of the most serious problems connected to orthopaedic surgery, since they 
can cause important damages to patients [2,3], as implant failure and re-operation. Nowadays, the 
infections are defeated with the antibiotics use, but the increasing bacteria resistance has induced 
the researchers to found an alternative, such as orthopaedic implant devices realized using synthetic 
materials able both to be osteointegrated and to possess antibacterial properties [4-6].  
Silver is well known for its antibacterial properties against most of bacteria species [7-9] and the 
bacterial resistance to this element is nowadays a rare phenomenon. For this reason, many 
researchers are studying the possibility to overwork the peculiar characteristics of silver and its 
compounds to realize implant materials capable to prevent bacteria colonization and consequently 
infection diseases [10-15]. Unfortunately silver and its compounds become toxic towards cells and 
tissues when their concentration is higher than threshold. This fact led to use silver to coat, for 
example, the surfaces of devices as urinary catheters or external fixation pins for bone fracture 
healing. In the first case, the real efficacy of silver is already discussed and not even completely 
cleared, but toxicity does not represent a limitation to the use of silver, as cell tissues does not 
become in direct contact with silver coated surfaces for prolonged periods. On the other side, silver 
coated orthopaedic pins revealed a good protection against bacteria colonization, but the amount of 
silver found in patients blood after implant resulted higher than tolerable limit of toxicity [16]. The 
silver toxicity is a still open problem, in particular the discussion concerns its potential toxic effects 
at local level and/or systemic one; the first one, even less dangerous than the systemic toxicity, can 
cause argyria phenomena and cells pain around silver containing devices. 
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For this reason, the possibility to control the amount of silver and to limit its presence to the 
external surfaces of implant materials has become the main goal to realize safe devices, both in 
terms of compatibility towards host tissues and in terms of reduced bacteria adhesion onto implant’s 
surfaces. 
The aim of this work was the realization of glass-coated metallic devices showing a reduced affinity 
towards bacteria, obtained through a silver surface-enrichment, together with the maintenance of 
biocompatibility towards host tissues. Several methods can be used to coat a substrate with a glassy 
layer. Among them, lot of literature deals with enamelling, glazing, plasma-spray, spin casting, 
sputtering, electrophoresis and pulsed laser ablation. Thermal spraying is a well established 
technology commonly used to produce coatings for a wide variety of applications [17]. Thermal 
spray processes can be grouped into three major categories: plasma-arc spray, flame spray, and 
electric wire-arc spray. The plasma spray technique made easier the development of bioactive glass 
coating and composites [17-25] on titanium and its alloys. By multiple scanning of the substrate, 
coatings of the desired thickness, usually around 70-150 µm, can be easily developed. For these 
reasons, the plasma spray process was selected for the realization of the glass coatings in this work. 
In order to impart antibacterial properties to the glass coated substrates, the ion-exchange technique 
was used, following a patented and optimized experimental schedule. The glass selected for this 
study is a silica based glass, characterized by moderate bioactivity index, so is a good candidate for 
the realization of long-term stability bioactive coatings on bio-inert substrates. The glass 
composition was selected during previous studies, described in the first part of this work [26], 
aiming to reduce as much as possible the introduced silver on the glass surface, as well as to 
develop a glass composition which allowed the realization of coatings on metallic substrates 
(stainless steel and Ti6Al4V), in order to apply the ion exchange technique directly on coated 
devices. 
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2. Experimental 
2.1 Materials synthesis and characterization 
The glass chosen as plasma-sprayed coating on such substrates has the molar composition of 
57%SiO2, 3%Al2O3, 34%CaO and 6%Na2O (named SCNA). The glass has been prepared by 
melting reagent-grade reactants in a platinum crucible at 1500°C for 1h and then quenching the melt 
in water to obtain a frit, or pouring the melt in a copper mould to obtain regular shaped bars. After 
drying, the frit was ball milled in a planetary miller to obtain a powder. After milling, the powder 
was sieved down to 100 µm (the powder size was selected on the bases of technical requirements 
for plasma-spray process, performed by Eurocoating s.p.a.). The SCNA glass powder has been 
subjected to thermal characterizations by means of Differential Thermal Analysis (DTA-7-Perkin 
Elmer), Differential Scanning Calorimetry (DSC-7-Perkin Elmer) in order to determine its 
characteristic temperatures. Thermal Dilatometry (DMA-7-Perkin Elmer) was used in order to 
determine the thermal linear expansion coefficient (α) on bulk samples of 8x3x3 mm3 size, obtained 
by cutting the glass bars after a proper annealing process. 
Metal substrates selected for this work have been Ti6Al4V alloy and AISI316L steel, as the major 
part of implant devices for bone healing are realized with those alloys. Ti6Al4V substrates were 
provided as disks of 25mm diameter and 5mm height, and only one surface has been plasma-spray 
coated with SCNA glass; this geometry was specifically selected in order to perform mechanical 
adhesion tests. AISI316L samples were provided as cylinders of 5mm diameter and 12mm height 
and their entire surface has been coated. Metal substrates have been previously sand-blasted with 
alumina and ultrasonically cleaned. The plasma spray process parameters have been selected by 
Eurocoating s.p.a., on the basis of preliminary experiences. From now on SCNA coated steel 
samples will be called GCS, while SCNA coated Ti-alloy samples will be called GCT. The main 
characteristics of coated samples are summarized in table 1. The coatings thickness has been 
evaluated through SEM observations of different sample sections and calculated in many section 
point to verify the thickness homogeneity. 
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2.2 Mechanical tests 
The uniformity and good coating adhesion are important parameters to guarantee an optimal 
prosthesis adherence and bond to tissue, avoiding its instability. The determination of glass coatings 
adhesion on titanium alloy substrates was carried out in accordance with ISO standard 13779-4 by 
Eurocoating s.p.a. to evaluate the interfacial bonding strength. The adhesion on stainless steel 
substrates was only evaluated by qualitative observations, since the geometry of the provided 
sample was not adequate for tensile tests. 
 
2.3.  Surface modification 
Sets of both GCS and GCT samples have been subjected to a silver ion-exchange process to modify 
glass surface by introducing a controlled amount of silver ions. The ion-exchange process is 
patented [27] and is based on a thermo-chemical treatment of the glassy material in an opportune 
solution, capable to exchange mono-valent ions, coming from the glass, with silver ions, coming 
from the solution itself. The parameters that regulate such process are respectively: silver ions 
concentration of the solution, time and temperature of the process; by opportunely tuning ion-
exchange parameters it is possible to modulate both the amount of silver ions introduced in the glass 
and their concentration profile along the glass material section [28,29]. Such process can be applied, 
simply by tuning the process parameters according to the material composition and characteristics, 
to any material belonging to the classes of glasses, glass-ceramics and ceramics. This kind of silver-
doping treatment of glasses, glass-ceramics and ceramics surfaces, allows imparting antibacterial 
properties to a wide range of materials, without inducing any drastic change in their peculiar 
properties. 
GCS and GCT samples were subjected to the silver ion-exchange treatment in different aqueous 
solutions containing different amounts of silver ions. In this work different ion-exchange conditions 
have been evaluated, by varying the solution concentration between 0.5M and 0.05M, an 
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exchanging time and temperature process respectively between 30÷50 minutes and 80÷100°C; 
afterwards two silver ions concentrations were selected: one more concentrated (called I) and 
another one less (II). Glass-coated silver-ion-exchanged samples will be called, from now on, Ag-
GC-I and Ag-GC-II; since any significant difference between GCS and GCT samples was observed, 
neither before nor after the ion-exchange treatment, all coated samples will be named with the same 
connotation.  
GC and Ag-GC samples were then analyzed by means of X-Ray diffraction (XRD), using Bragg 
Brentano camera geometry and Cu-Kα incident radiation, to verify if any structural change or 
crystallization phenomena occurred due to plasma-spray process and/or silver ion-exchange 
treatment. Scanning electron microscopy (SEM Philips 525M) observations and energy dispersion 
spectrometry (EDS) were performed to evaluate morphology and composition both on GC and Ag-
GC samples. 
 
2.4.  In vitro bioactivity test 
The term “bioactivity” refers to the ability of  some silica-based glasses to induce in vitro, by 
immersion in a simulated body fluid, the formation of a semi-crystalline hydroxycarbonatoapatite 
(HCA) rich layer. This behaviour is considered as an indication of their in vivo bioactivity (natural 
bonding ability to living tissues) through a mechanism that starts with a rapid ions exchange 
between the alkaline ions from the glass surface and the hydrogen ions from the solution, followed 
by the formation of silanols, which then undergo polycondensation to develop a silica gel layer. 
This layer promotes the adsorption of Ca++ and PO43- ions from the solution. These ions 
subsequently react, forming the HCA layer.  In vitro bioactivity tests were performed soaking GC 
and Ag-GC-I samples on simulated body fluid solution (SBF, as reported by Kokubo [30]) at 
biological temperature (37°C) for periods up to one month. Coatings and silver modified coatings 
reactivity was evaluated, after soaking in SBF, by means of SEM observation. The bioactivity test 
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was performed only on Ag-GC-I, samples subjected to the most severe ion-exchange condition,  to 
evaluate the possible effect of silver introduction. 
 
2.5. Leaching test 
The amount of released silver ions from Ag-GC surfaces was investigated on a set of three samples, 
having the same size and surface area (120 mm2). The procedure followed in this work was the 
same reported in a previous paper [26]: the samples were soaked into 30 ml of SBF solution 
maintained at 37°C up to 30 days. Grafite furnace atomic adsorption spectroscopy (GFAAS) 
analyses were performed on 1 ml of SBF spiked from each soaking solution after 3 hours, 1day, 2, 
7, 14 and 30 days of dipping. For comparative purposes also the pure SBF and the solutions in 
contact with GC have been analysed.  
 
2.6  Biocompatibility test 
Ag-GC-II biocompatible behavior has been verified using a fibroblast cell line; the cells have been 
cultured at 37 °C in 95% air/ 5%CO2 in DMEM supplemented with 10% fetal bovine serum (FBS, 
Sigma), penicillin (100 U ml-1 ), streptomycin (100 µg ml-1 )  and L-glutammine 0.03%.  
Biocompatibility tests consisted in fibroblasts adhesion and proliferation studies, performed using a 
starting cell density of 104 cells/cm2; incubated cells have been counted in a Burker camera after 
being removed with SDS solution from samples surface, respectively after 6 hours culture, to 
evaluate their adhesion,  and 24 hours culture to estimate the proliferation.  
Ag-GC-II behaviour has been compared with GC sample and with a control one; both adhesion and 
proliferation have been investigated on a set of three samples. 
 
2.7 Antibacterial test 
The zone of inhibition test [31] was performed on Ag-GC samples and on GC as control. A 
Staphylococcus Aureus standard stock (ATCC 29213) was used to characterize Ag-GC-I and Ag-
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GC-II samples; furthermore the inhibition halo of Ag-GC-I was observed employing one stock 
isolated from human prosthetic infection: a bacterial broth has been prepared dissolving a S. Aureus 
disk in 5ml of brain heart infusion; after overnight incubation at 37°C, 10µl of the suspension have 
been spread on a Blood-Agar plate and incubated 24 hours in order to allow the bacterial colonies 
growth.  
A standard 0.5 Mc Farland (containing approximately 1 – 2 ⋅108 CFU/ml)  solution was prepared 
dissolving some bacterial colonies in a physiological solution (turbidity has been evaluated by 
optical instrument – Phoenix Spec BD McFarland), an aliquot of  this suspension has been spread  
on Mueller Hinton agar plates. Silver containing samples surfaces were drawn close to agar plate 
and incubated 24 hours at 35°C.   
Broth dilution tests have been also performed on Ag-GC-I and Ag-GC-II samples: a 0.5 Mc Farland 
suspension has been prepared in the same way described above, an aliquot of bacterial suspension 
has been introduced in Mueller Hinton broth tubes in order to obtain suspensions approximately 
containing 5⋅105 CFU/ml. After 24h incubation at 35°C tubes’ turbidity has been optically 
evaluated. 
As for samples washing and vortexing solutions have been analyzed in order to quantify colony 
forming units (CFU). Washing solution has been prepared by rapid rinsing of sample in 
physiological solution, while the vortexing one by one minute 50Hz vortex of sample in 
physiological solution. Mc Farland index of each solution has been measured, then they have been 
serially diluted and spread on Blood-Agar plates, after overnight incubation at 35°C CFU have been 
counted on plates. 
The percentage reduction in bacteria count was calculated by the formula: 
100*
0
0
CFU
CFUCFU Ag−
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Where CFU0 is the number of colonies forming units counted on plate containing the solution of  
untreated samples and CFUAg is the number of bacteria counted on doped silver samples; this 
formula has been used as for adhered bacteria as for proliferated ones. 
All samples were previously dry sterilized at 170°C for 1 hour and all products for antibacterial 
analysis have been purchased from BD-Becton Dickinson. 
 
3. Results and discussion 
3.3 Thermo mechanical properties of the coatings 
Thermal analyses on SCNA powders measures Tg at 685°C. This temperature was detected in order 
to set the annealing procedure for the glass bars (for ten hours at 600°C), to be cut in small 
specimens for the determination of the thermal expansion coefficient (α). The value of α varies 
between 6,8·10-6 °C-1 and 8,6·10-6 °C-1 in the range from 100°C to 600°C. In this temperature 
interval, α for Ti6Al4V ranges between 8,7·10-6 °C-1 and 10·10-6 °C-1, while for AISI316L it ranges 
between 16·10-6 °C-1 and 17,5·10-6 °C-1 (being α for Ti-alloy nearer to the glass than the steel one). 
Taking into account the theories that describe how to control the interface between a glass coating 
and a metal substrate, the glass should have a slightly lower thermal expansion than the metal. This 
feature could induce only small compressive stresses in the glass coating, avoiding the generation of 
tensile thermal stresses during cooling from the processing temperature to room temperature, which 
can induce coating cracking or delaminating during processing. Bioactive glasses are typically 
silica-based glasses, with silica content below 60 wt.% (glasses with silica contents greater than 60 
wt.% are no longer bioactive). Most of these glasses have thermal expansion coefficients much 
higher than those of Ti alloys. Thermal expansion of the glass can be reduced by increasing the 
SiO2 content, or by adding Al2O3 in the composition, but this reduces bioactivity as well [32,33], so 
these compositional modifications should be done in a very limited amount, as in the present work.  
Despite the differences in the thermal expansion coefficient between the glass and the two metal 
substrates, no significant differences between the two metals were observed after plasma spray 
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coating, verifying that, for the plasma spray technique, the different thermal properties of the 
coating, respect to the substrate one, do not affect in great amount the main characteristics of the 
resulting coated sample, as could happen, on the contrary, during enamelling processes. 
Moreover, any significant difference can be observed between GCS and GCT samples, being the 
structure, the morphology and the mechanical adhesion of the glass coating the same on both 
metals’ substrates. Table 1 summarizes some dimensional features of the coated GCS and GCT 
samples. The coating adhesion, estimated on GCT samples showed a value up to 41.2 ± 9.6 MPa. 
This value is higher than those detected for various plasma spray coatings of similar thickness made 
of hydroxyapatite, glasses or glass-matrix composites on Ti6Al4V substrates, as reported in 
literature [24,34,35]. 
 
3.2 Phase analysis (XRD) and morphology. 
The plasma spray process did not provoke any crystallization phenomena on the SCNA glass, as 
clearly evident in figure 1.a and figure 1.b, where the XRD patterns of the as done glass and a 
titanium alloy coated sample have been reported: the only difference is represented by the signal of 
Ti substrate at 40.3°. Figure 1.c reports the XRD pattern of a coated GCT sample after ion exchange 
with silver solution, where no evidence of structural modifications after ion exchange on the glass 
coating appears.  
As regards the effect on the substrates of silver ion-exchange process, both metallic substrates did 
not undergo any significant change in their structure or morphology, thus verifying that the process 
did not provoke metal corrosion or structure modifications (Figure 2). Morphological observations 
by SEM on coated samples did not evidence any dissolution phenomena or variation in the 
morphology occurring on the glass after silver ion-exchange process. Figure 3 shows a detail of the 
interface between the Ti substrate and the coating after ion exchange (performed after the sample 
sectioning) where no sign of corrosion are evident. The material composition, by means of EDS 
measurements, evidenced the presence of silver on Ag-GC surfaces (Figure 4). This is a further 
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confirm that the ion-exchange process allow only the modification of the outer layer of glass 
surfaces. 
 
3.3.Leaching tests 
Since the specific surface area of GC samples is reasonably higher than that of SCNA massive 
samples, we can expect that all processes linked to surface mechanisms would be influenced and 
could affect the final characteristics of the device. So, though silver ion-exchange process was 
performed in the same conditions used for massive SCNA glass samples (as reported in the first part 
of the present study [26], data collected by GFAAS measurements showed higher amounts of 
released silver ions, on equal time both for Ag-GC-I and Ag-GC-II. Figure 5a show the release 
trend comparison between silver containing coatings, ion-exchanged in both Ag+ concentration 
selected for this work, and glass massive samples. Figure 5b reports the comparison of silver 
released rate from different samples. The greater part of silver is released during the first days of 
contact with SBF solution. 
Leaching test show an amount of released silver in agreement with previous works and with the 
chosen ion-exchange parameters: coatings, having a higher specific surface area, release a higher 
amount of silver, proportional to the silver concentration selected. The release trend of Ag-GC-I 
samples is lightly different from Ag-GC-II ones, probably the more critical conditions of ion-
exchange lead to a deeper diffusion of Ag ions and to a more gradual release. 
Nevertheless, in both condition, silver is fast released during the first day of immersion in the 
simulated body fluid; this aspect is very important because the first period after a surgical treatment 
is particularly dangerous for the infections incidence, so it is very helpful to inhibit the bacteria 
adhesion immediately after a device implant, when a fight to colonize its surfaces occurs between 
host cells and bacteria, and promote the regeneration of a healthy tissue. 
 
3.4.Bioactivity 
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The in vitro tests, performed only on Ag-GC-I, confirm the low bioactivity of the glass, as verified 
in a previous work [14]. Since the glass maintains the same degree of bioactivity both after the ion-
exchange and after the plasma spray process, the introduced silver, as well as the plasma spray 
process, are completely irrelevant on the glass reactivity. This result is very interesting in 
expectation to apply the ion-exchange technique to a medical devices, because this technique does 
not influence the substrate characteristics, both the bulk and surface properties, useful to promote 
the osteo-integration with the surrounding tissues.    
 
3.5.Biocompatibility 
Biocompatibility tests confirmed the safety of materials also in the case of Ag-treated samples. 
Figure 6 shows the amount of alive cells counted on untreated and treated samples and on control 
ones, after 6 hours for the adhesion and after 24 hours for the proliferation evaluation. The 
fibroblasts amount adhered and proliferated on GC and on Ag-GC samples is lightly lower than 
cells grown on control, but the cells grown on silver doped samples are comparable with those on 
untreated glass. These cytotoxicity tests confirm the safety of silver doped coatings toward 
fibroblast cells. 
 
3.6 Antibacterial properties 
The zone of inhibition tests disclose the antibacterial behaviour of both Ag-GC-I and Ag-GC-II 
doped samples: as expected the inhibition halo due to Ag-GC-I (3-4 mm) is larger than Ag-GC-II 
halo (2 mm), indeed Ag-GC-I was obtained using higher concentration silver solution than Ag-GC-
II. Figure 7.a and figure 7.b show two Mueller Hinton Agar plate including everyone three silver 
doped samples and one untreated as control. 
A further confirmation of the antibacterial behaviour of Ag-GC comes from the zone of inhibition 
test on the stock isolated from human prosthetic infection: Ag-GC-I show a halo of about 5 mm, 
larger than halo obtained with a standard stock (Figure 8). 
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Broth dilution tests (Figure 9) show an important antibacterial effect of Ag-GC-I and a more limited 
one for Ag-GC-II, nevertheless Ag-GC-I show a reduction of 99.8% for adhered bacteria and of 
99.5% for the bacteria proliferated closely the material. Ag-GC-II provide an adhered bacteria 
reduction of  94.8% and of 78.7 % for proliferated colonies. 
Mc Farland index measurement confirm this trend (Figure 10), there is a gap of 0.53 Mc Farland 
between GC and Ag-GC-II, and a gap of 2.02 Mc Farland between GC and Ag-GC-I. 
In summary, antibacterial test showed a marked bacteriostatic behaviour of Ag-treated samples, 
proportional to the introduced and consequently released silver amount. The antibacterial effect is 
proved by different tests: broth dilution test, Mc Farland index evaluation and zone of inhibition 
test; the last one, performed on a stock isolated from human prosthetic infection, is an important 
confirmation of the antibacterial behaviour of silver doped samples.  
As seen in the previous work, the introduced silver has a bacteriostatic effect, it inhibits the 
proliferation and most of all the adhesion of bacteria on coatings surfaces, but does not kill bacterial 
cells; nevertheless this is actually the aim of this research: the realization of a biocompatible and 
antibacterial glass-coated metallic devices. Future works will evaluate the possible bactericidal 
effect of silver ions released from Ag-GC samples.  
 
4. Conclusions 
A silica based glass with a low degree of bioactivity was successfully used to coat Stainless steel 
and Ti6Al4V samples By Plasma Spray in air (APS). The coated samples have been treated by a 
patented surface treatment to enrich their surface with small amounts of silver ions, in order to 
induce antibacterial activity. The parameters of the treatment have been carefully selected in order 
to obtain a surface with bacteriostatic properties but no danger for cytotoxicity; in particular the 
total amount of the released silver is under the toxic threshold, and on the glass surface any silver 
compound potentially responsible of toxic effect, precipitated during soaking. 
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The surface silver enrichment did not affect the morphology and the structure of the coatings. The 
bacteriostatic effect of the as treated coatings has been proved by three different antibacterial tests; 
at the same time the cytotoxicity test confirm the safety of materials and most of all of silver-doped 
samples toward fibroblast cells. 
The plasma spray process did not induce any changing in glass composition and reactivity and the 
realized coatings have a good mechanical strength. The SCNA glass powders can be used to coat 
several metallic devices, on which the ion-exchange technique can be applied to impart antibacterial 
properties.                                                                                                                                                                                                                             
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Table legend 
Table 1: Dimensional parameters of GCS and GCT 
 
 
Figure legends 
 
Figure 1:  XRD spectra of: a) SCNA glass, b) GCT and c) GCT after ion-exchange. 
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Figure 2: Influence of ion-exchange on Ti6Al4V substrate. 
 
Figure 3:  The interface between the Ti substrate and the coating after ion exchange  
 
Figure 4:  EDS analyses on a) GC, b) Ag-GC-I and c) Ag-GC-II 
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Figure 5:  Comparison of silver release trend from massive glass and coatings 
 23
 
Figure 6:  Number of alive cells adhered (6h) and proliferated (24h) on control (PE), glass samples 
(GC) and Ag-treated samples (AgGC) 
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Figure 7:  Zone of inhibition test: inhibition halo of a) three Ag-GC-I and one GC as control, b) 
three Ag-GC-II and one GC as control 
 
Figure 8: Zone of inhibition test on the stock isolated from human prosthetic infection of four Ag-
GC-I and one GC as control 
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Figure 9:  
CFU proliferated (a)  and adhered (b)on GC      , Ag-GC-I      and Ag-GC-II       
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Figure 10:  
Mc Farland index of GC     , Ag-GC-I     and Ag-GC-II 
 
 
 
 
 
 
